Diagnosis and treatment of coronavirus disease 2019 (COVID-19): Laboratory, PCR, and chest CT imaging findings

Int J Surg. 2020 Jul:79:143-153. doi: 10.1016/j.ijsu.2020.05.018. Epub 2020 May 15.

Abstract

Since December 2019, more than 3 million cases of coronavirus disease 2019 (COVID-19) and about 200,000 deaths have been reported worldwide. The outbreak of this novel disease has become a global health emergency and continues to rapidly spread around the world. Based on the clinical data, approved cases are divided into four classes including mild, moderate, severe, and critical. About 5% of cases were considered critically ill and 14% were considered to have the severe classification of the disease. In China, the fatality rate of this infection was about 4%. This review focuses on currently available information on the etiology, clinical symptoms, diagnosis, and mechanism of action of COVID-19. Furthermore, we present an overview of diagnostic approaches and treatment of this disease according to available findings. This review paper will help the physician to diagnose and successfully treat COVID-19.

Keywords: COVID-19 vaccine; Chloroquine; Coronavirus; Coronavirus infection; Respiratory tract infections; Viral pneumonia.

Publication types

  • Review

MeSH terms

  • Antiviral Agents / therapeutic use
  • Betacoronavirus
  • COVID-19
  • COVID-19 Drug Treatment
  • COVID-19 Testing
  • China / epidemiology
  • Clinical Laboratory Techniques
  • Coronavirus Infections / diagnosis*
  • Coronavirus Infections / diagnostic imaging
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / transmission
  • Critical Illness
  • Humans
  • Infectious Disease Transmission, Professional-to-Patient
  • Lung / diagnostic imaging
  • Pandemics
  • Pneumonia, Viral / diagnosis*
  • Pneumonia, Viral / diagnostic imaging
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / transmission
  • Polymerase Chain Reaction
  • Risk Factors
  • SARS-CoV-2
  • Tomography, X-Ray Computed

Substances

  • Antiviral Agents